Andersen, S. W., Trentham-Dietz, A., Figueroa, J. D., Titus, L. J., Cai, Q., Long, J., . . . Newcomb, P. A. (2013). Breast cancer susceptibility associated with rs1219648 (FGFR2) and postmenopausal hormone therapy use in a population-based U.S. study.

Andersen, Shaneda Warren, Amy Trentham-Dietz, Jonine D. Figueroa, Linda J. Titus, Qiuyin Cai, Jirong Long, John M. Hampton, Kathleen M. Egan, and Polly A. Newcomb. Breast Cancer Susceptibility Associated With Rs1219648 (FGFR2) and Postmenopausal Hormone Therapy Use in a Population-based U.S. Study. 2013.

Andersen, Shaneda Warren, et al. Breast Cancer Susceptibility Associated With Rs1219648 (FGFR2) and Postmenopausal Hormone Therapy Use in a Population-based U.S. Study. 2013.